ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Forest Hills Lab is filing an IND to initiate a clinical phase 2 study on Parkinson's disease with the US FDA
March 24, 2021Forest Hills Partners Hong Kong, S.A.R., China Limited (also known as Forest Hills Lab) is ready to file an Investigative New Drug (IND) application with the US FDA in April 2021 to assess tolerability and efficacy with one of its drug candidates, namely
Pharma Sources Insight January 2025
